Chinese breast cancer patients with CYP2D6 *10 mutant genotypes have a better prognosis with toremifene than with tamoxifen-Reference-Cited by-同舟云学术

Chinese breast cancer patients with CYP2D6 *10 mutant genotypes have a better prognosis with toremifene than with tamoxifen

Published:2021-06-30 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Wang Hongyue¹,Ma Xinchi²^ORCID,Zhang Bin³,Zhang Yaotian²,Han Ning²,Wei Linlin²,Sun Chaonan²,Sun Shichen²,Zeng Xue²,Guo Hong²,Li Yubing²,Zhang Yanyu²,Zhao Jiaming²,Qin Zilan²,Liu Zhuang²,Zhang Na²

Affiliation:

1. Department of Science Research and Academic, Cancer Hospital of China Medical University Liaoning Cancer Hospital & Institute Shenyang Liaoning Province P. R. China

2. Department of Breast Radiation Oncology, Cancer Hospital of China Medical University Liaoning Cancer Hospital & Institute Shenyang Liaoning Province P. R. China

3. Department of Breast Surgery Cancer Hospital of China Medical University Liaoning Cancer Hospital & Institute Shenyang Liaoning Province P. R. China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13571

Reference30 articles.

1. The epidemic and characteristics of female breast cancer in China;Ying Zheng;China Oncology,2013

2. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

3. The 20‐year results of 5year hormone therapy in breast cancer:early Breast Cancer Trialists' Collaborative Group(EBCTCG);Traub L;Internist (Berl),2018

4. Breast Cancer, Version 3.2018

5. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review;Open Biology;2024-06

2. Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer;Egyptian Journal of Medical Human Genetics;2022-08-14